| Literature DB >> 35581488 |
Anna Grossauer1, Victoria Sidoroff2, Beatrice Heim1, Klaus Seppi3.
Abstract
Without any disease-modifying treatment strategy for multiple system atrophy (MSA), the therapeutic management of MSA patients focuses on a multidisciplinary strategy of symptom control. In the present review, we will focus on state of the art treatment in MSA and additionally give a short overview about ongoing randomized controlled trials in this field.Entities:
Keywords: Autonomic dysfunction; Motor and non-motor symptoms; Multiple system atrophy; Symptomatic treatment
Year: 2022 PMID: 35581488 DOI: 10.1007/s12311-022-01411-6
Source DB: PubMed Journal: Cerebellum ISSN: 1473-4222 Impact factor: 3.847